High serum free IL-18 is associated with decreased omalizumab efficacy: findings from a 2-year omalizumab treatment study-Reference-Cited by-同舟云学术

High serum free IL-18 is associated with decreased omalizumab efficacy: findings from a 2-year omalizumab treatment study

Published:2020-05-20 Issue:9 Volume:58 Page:1133-1142
ISSN:0277-0903
Container-title:Journal of Asthma
language:en
Short-container-title:Journal of Asthma

Author:

Morimoto Chie¹^ORCID,Matsumoto Hisako¹,Tajiri Tomoko¹²,Gon Yasuhiro³,Ito Reiko³,Hashimoto Shu³,Suzukawa Maho⁴,Ohta Ken⁴,Izuhara Kenji⁵,Ono Junya⁶,Ohta Shoichiro⁷,Ito Isao¹,Oguma Tsuyoshi¹,Kanemitsu Yoshihiro¹²,Nagasaki Tadao¹,Izuhara Yumi¹,Niimi Akio²,Hirai Toyohiro¹

Affiliation:

1. Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan

2. Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University School of Medical Sciences, Nagoya, Japan

3. Division of Respiratory Medicine, Department of Internal Medicine, Nihon University, Tokyo, Japan

4. Respiratory Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan

5. Division of Medical Biochemistry, Department of Biomolecular Sciences, Saga Medical School, Saga, Japan

6. Shino-Test Corporation, Sagamihara, Japan

7. Department of Laboratory Medicine, Saga Medical School, Saga, Japan

Funder

the Adaptable and Seamless Technology Transfer Program through target-driven R&D

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/02770903.2020.1766061

Reference51 articles.

1. ‘Real-life’ effectiveness studies of omalizumab in adult patients with severe allergic asthma: systematic review

2. “Real-life” Effectiveness Studies of Omalizumab in Adult Patients with Severe Allergic Asthma: Meta-analysis

3. Comprehensive efficacy of omalizumab for severe refractory asthma: a time-series observational study

4. Exploring the Effects of Omalizumab in Allergic Asthma

5. A randomized multicenter study evaluating Xolair persistence of response after long-term therapy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Necesidades no cubiertas en asma alérgica grave;Open Respiratory Archives;2023-10

2. Predictive biomarkers for response to omalizumab in patients with severe allergic asthma: a meta-analysis;Expert Review of Respiratory Medicine;2022-06-23